Pay in 4 interest-free payments of $6.01 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
One injection per week minimizes these risks
Each peptide plays a distinct role in how the body repairs, renews, and maintains balance
Important safety information: Tirzepatide carries a boxed warning for risk of thyroid C-cell tumors and is contraindicated in patients with personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
Microbial contamination is invisible to the naked eye at concentrations that still pose risk
The evidence base is overwhelmingly preclinical, and there are no completed, published Phase 2 or 3 human efficacy trials only early-stage safety work [9]
Skofitsch, G., Wimalawansa, S
US$ 25.28
US$ 29.76
US$ 29.22
US$ 24.16
